MedPath

Continued Safety Evaluation of FB-401 in Children, Adolescents and Adults (2 Years and Older) With Mild to Moderate Atopic Dermatitis Previously Enrolled in the FB401-01 Study

Phase 2
Terminated
Conditions
Atopic Dermatitis
Interventions
Biological: FB-401
Registration Number
NCT04936113
Lead Sponsor
Forte Biosciences, Inc.
Brief Summary

The purpose of this study is to evaluate the continued safety and tolerability of FB-401 in subjects 2 years of age or older with mild to moderate atopic dermatitis. FB-401 will be applied topically for up to 48 additional weeks and subjects will be evaluated for safety.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
36
Inclusion Criteria
  • Participated in Protocol FB401-01, completed through Week 20 visit and able to directly enroll into this (FB401-02) study
  • Refrain from use of all other atopic dermatitis treatments, unless given permission by medical monitor
Exclusion Criteria
  • Subject experienced a serious adverse event or severe adverse event attributable to study drug in Protocol FB401-01
  • Severe concomitant illness that, in the Investigator's opinion, would adversely affect subject participation in the study, whether medical or psychological
  • Pregnant (or planning to become pregnant during the period of the study) or lactating females

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
FB-401FB-401FB-401 applied topically
Primary Outcome Measures
NameTimeMethod
Number of adverse events52 weeks

Safety evaluations

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (6)

Center for Dermatology Clinical Research, Inc.

🇺🇸

Fremont, California, United States

Multi-Specialty Research Associates, Inc.

🇺🇸

Lake City, Florida, United States

Cyn3rgy Research

🇺🇸

Gresham, Oregon, United States

MedaPhase, Inc

🇺🇸

Newnan, Georgia, United States

DS Research

🇺🇸

Louisville, Kentucky, United States

Bellaire Dermatology Associates

🇺🇸

Bellaire, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath